Page last updated: 2024-09-03

reboxetine and dsp 4

reboxetine has been researched along with dsp 4 in 3 studies

Compound Research Comparison

Studies
(reboxetine)
Trials
(reboxetine)
Recent Studies (post-2010)
(reboxetine)
Studies
(dsp 4)
Trials
(dsp 4)
Recent Studies (post-2010) (dsp 4)
626193184572080

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harkin, A; Kelly, JP; Leonard, BE; Morris, K; O'Donnell, JM1
Cryan, JF; Lucki, I; Page, ME1
Casarotto, PC; Crestani, CC; Diniz, CRAF; Joca, SRL; Pereira, VS; Rodrigues, M1

Other Studies

3 other study(ies) available for reboxetine and dsp 4

ArticleYear
Modulation of MK-801-induced behaviour by noradrenergic agents in mice.
    Psychopharmacology, 2001, Mar-01, Volume: 154, Issue:2

    Topics: Adrenergic Agents; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Ataxia; Benzylamines; Clonidine; Desipramine; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Frontal Lobe; Male; Mesencephalon; Mice; Morpholines; Motor Activity; Norepinephrine; Prazosin; Reboxetine; Stereotyped Behavior

2001
Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test.
    European journal of pharmacology, 2002, Feb-02, Volume: 436, Issue:3

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Benzylamines; Dose-Response Relationship, Drug; Frontal Lobe; Hypothalamus; Locus Coeruleus; Male; Morpholines; Neurotoxins; Norepinephrine; Oxidopamine; Rats; Rats, Sprague-Dawley; Reboxetine; Swimming; Sympatholytics; Tegmentum Mesencephali

2002
Monoamine involvement in the antidepressant-like effect induced by P2 blockade.
    Brain research, 2017, Dec-01, Volume: 1676

    Topics: Animals; Antidepressive Agents; Benzylamines; Biogenic Monoamines; Dose-Response Relationship, Drug; Fenclonine; Fluoxetine; Frontal Lobe; Hippocampus; Male; Mice; Morpholines; Motor Activity; Neurotransmitter Uptake Inhibitors; Purinergic P2 Receptor Antagonists; Random Allocation; Reboxetine

2017